.
.

Continuing Education Activities

Here at JADPRO CE, you can find a valuable array of accredited educational opportunities: it’s the place to get your credits and update your learning in oncology. We provide advanced practitioners like you with a wide range of continuing education, covering the most current topics in several formats so you can choose the way you want to learn. You'll find that our CE offerings are easy to navigate. You can sort by topic and/or format, or simply browse the site and get started!

Topic

Format

      Quick Tips →

*Sorted by program start date
CHRONIC LYMPHOCYTIC LEUKEMIA
Print

Understanding the Role of Targets and Pathways in the Treatment of Chronic Lymphocytic Leukemia

CLL is the most common leukemia in Western countries, with a  population primarily over 70 years of age. Frailty and comorbidities are common concerns with established chemoimmunotherapy, but new FDA-approved therapies have led to specialized, specific treatments for the different stages of CLL. 

Posted: 12/19/2017 / Expires: 12/18/2018

Credits/Contact Hours: 3.0

ORAL ONCOLYTICS
Print

The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics

Almost 40% of the total cost of targeted therapies in the US are now for oral formulations, up from 26% in 2010. This increase calls for APs to act as practice-to-patient liaison with limited resources.  This education will focus on how APs can overcome a variety of barriers for patient nonadherence to oral therapies and encourage patients to continue their regimens. 

Posted: 12/8/2017 / Expires: 12/7/2018

Credits/Contact Hours: 1.0

BIOSIMILARS
Print

Integrating Biosimilars Into Oncology Practice: Implications for the Advanced Practitioner

Over the past two decades, biologics have had a huge impact on the treatment of cancer in multiple tumor types, and in many cases these agents have improved outcomes and survival. In oncology, a growing number of biosimilars have been approved and are in clinical use, with more in the FDA pipeline.

Posted: 11/16/2017 / Expires: 11/16/2018

Credits/Contact Hours: 0.75

MOLECULAR TESTING
Print

The Emerging Role of Molecular Testing in Non–Small Cell Lung Cancer

A rapidly emerging concept that holds the promise of altering the natural history and subsequently outcomes for cancer patients is that of precision—or personalized—medicine. There is an immediate and growing need to alert advanced practitioners about the role molecular profiling has in the treatment of non–small cell lung cancer, from a primarily prognostic role to one that can also provide predictive guidance regarding the choice of a specific therapy. 

Posted: 10/19/2017 / Expires: 10/18/2018

Credits/Contact Hours: 1.0

MOLECULAR TESTING
Print

The Emerging Role of Molecular Testing in Ovarian Cancer

 A rapidly emerging concept that holds the promise of altering the natural history and subsequently outcomes for cancer patients is that of precision—or personalized—medicine. There is an immediate and growing need to alert advanced practitioners about the role molecular profiling has in the treatment of ovarina cancer, from a primarily prognostic role to one that can also provide predictive guidance regarding the choice of a specific therapy. 

Posted: 10/19/2017 / Expires: 10/18/2018

Credits/Contact Hours: 1.0

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.